RESOLVE™ PORTFOLIO
A portfolio of solutions for cancer resolution
Built for the critical window between suspicion and diagnosis, RESOLVE™ delivers clarity at the moment it matters most: when symptoms, signs, or findings raise the suspicion of cancer.
THE Portfolio for Cancer Resolution
01
Where Suspicion Meets Science.
RESOLVE™ is a family of assays built on a single scientific core—each one designed for a different moment when a patient is told we need to look closer.
02
Where Biology Comes First.
Every RESOLVE™ assay reads the same fundamental signal: cfDNA methylation, the earliest molecular marker of cancer emergence. One foundation. Compounding evidence across every application.
03
When Answers Can’t Wait.
RESOLVE™ is built for patients whose symptoms, signs, or findings already point toward cancer—when every day of uncertainty is a day too long.
Where RESOLVE™ Creates Clarity
Where RESOLVE™
fits in care
RESOLVE solutions bring clarity to pivotal moments in cancer care, including:
- Closer evaluation of findings
- Resolution of concerning signs or symptoms
- Prioritization of downstream work-up
- Longitudinal follow-up
RESOLVE is intentionally modular, enabling appropriate use based on timing, biology, and clinical need.
